Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions Wall Street Sentiment on BlackRock A Balanced Outlook Amid Market Uncertainty Telecom CEO Warns Europe Risks Connectivity Blackout with Starlinks Satellite Dominance Baird Raises Price Target on RideNow Group RDNW on Strong SameStore Sales Performance Wingstop Shares Slide 12 After Earnings Profit Misses Estimates AnheuserBusch InBev Shares Dip as Sales Miss Estimates DTE Energy Q1 2026 Earnings EPS Misses Estimates Debenture Holders See Modest Gain ULTA Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains on Resilient Demand USBC Q1 2025 Earnings Narrowing Loss Exceeds Expectations Addentax Group Corp Q1 2025 Earnings Net Loss Narrowing as Stock Gains 26 BeyondSpring Q1 2026 Earnings Narrowed Loss Per Share and Positive Stock Movement Volato Group Inc SOAR Q2 2025 Earnings Positive EPS Reported Amid Market Caution Catalyst Pharmaceuticals CPRX Holds Steady Near Support as Volume Remains Subdued LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Alzamend Neuro Inc ALZN Stalls Near Support Consolidation or Caution for This Alzheimers Play Xcel Energy XEL Hovers Near 81 Amid Narrow Trading Range Karbon Capital Partners Corp KBON Holds Steady at 1009 as Stock Consolidates Near Support ixigo Partners with Uber and redBus to Integrate Cab and Bus Bookings into Train App USAS Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Negative Surprise Rubrik Inc RBRK Rallies 278 as Momentum Builds Toward Key Resistance PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent GTLB Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher FTDR Q1 2026 Earnings EPS Surpasses Estimates with 587 Beat JCAP Q1 2026 Earnings EPS Surprise Lifts Expectations Amid Narrow Revenue Disclosures Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment Xeris Biopharma Holdings Inc XERS Q1 2026 Earnings EPS Surprise Turns Positive as Stock Dips ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline